Aie001 50243 — Boston, Massachusetts

Aie001 50243 is a clinical research site located in Boston, Massachusetts, United States 02114-3117.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Aie001 50243 has participated in 1 clinical trials.

Therapeutic areas: Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aie001 50243?

Aie001 50243 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aie001 50243 conducted?

Aie001 50243 has 1 clinical trials on record. Their work covers Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis.

Is Aie001 50243 accredited by Crixeo Health?

Aie001 50243 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aie001 50243?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.